Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01297270
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 658
Not applicableStudy completedNCT01375881
What this trial is testing

Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice

Who this might be right for
HIV Infections
Janssen-Cilag S.p.A. 31
Large-scale testing (Phase 3)Study completedNCT04820530
What this trial is testing

Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Ended earlyNCT02213744
What this trial is testing

MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHER2 Positive Breast Cancer
Merrimack Pharmaceuticals 113
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Testing effectiveness (Phase 2)Ended earlyNCT05308901
What this trial is testing

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Who this might be right for
Melanoma, Uveal
Providence Health & Services 6
Testing effectiveness (Phase 2)Looking for participantsNCT07380984
What this trial is testing

PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Ruijin Hospital 47
Testing effectiveness (Phase 2)Ended earlyNCT00509366
What this trial is testing

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Duke University 101
Not applicableLooking for participantsNCT07045688
What this trial is testing

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

Who this might be right for
H. Pylori Infection
Sohag University 150
Testing effectiveness (Phase 2)Ended earlyNCT00118131
What this trial is testing

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Medicine and Dentistry of New Jersey 49
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00158470
What this trial is testing

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 100
Post-approval studies (Phase 4)Study completedNCT01275625
What this trial is testing

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Who this might be right for
HIV
ViiV Healthcare 98
Not applicableStudy completedNCT05214963
What this trial is testing

Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

Who this might be right for
Restless Legs Syndrome
Noctrix Health, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT02337829
What this trial is testing

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Acerta Pharma BV 48
Testing effectiveness (Phase 2)Study completedNCT00661830
What this trial is testing

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 103
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Large-scale testing (Phase 3)Study completedNCT00389207
What this trial is testing

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Who this might be right for
HIV Infections
Boehringer Ingelheim 576
Large-scale testing (Phase 3)Study completedNCT02696785
What this trial is testing

Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis

Who this might be right for
Spondyloarthritis
Eli Lilly and Company 341
Testing effectiveness (Phase 2)Study completedNCT00100633
What this trial is testing

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation